Lung Adenocarcinoma - 25 Studies Found
| Active, not recruiting |
: Molecular Analysis of 150 Lung Adenocarcinoma : Lung Adenocarcinoma : 2016-07-20 : Genetic: Sequencing Tumour samples are coming from routine histopathological procedure. They are used wi |
| Active, not recruiting |
: Expression of AMP-activated Protein Kinase (AMPK) Protein in Lung Adenocarcinoma : Lung Adenocarcinoma : 2010-11-24 |
| Active, not recruiting |
: Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment Strategy : Lung Adenocarcinoma : 2011-11-28 : Other: CT, PET, copy number alteration Duel-energy CT, PET, copy number alteration |
| Not yet recruiting |
: Clinical Trial of Erlotinib and Pemetrexed for Maintenance Treatment in Lung Adenocarcinoma : Lung Adenocarcinoma : 2015-03-22 : Drug: Erlotinib, Pemetrexed followed classical chemotherapy for 4 cycles, use Erlotinib orally for the m |
| Completed |
: Pemetrexed and Platinum Use in the Neoadjuvant Setting for Resectable Stage II and IIIA Lung Adenocarcinoma : Lung Adenocarcinoma : 2014-12-16 :
|
| Completed |
: Cetuximab in Patients With Lung Adenocarcinoma Receiving Erlotinib That Have Developed "Acquired Resistance" to Erlotinib : Lung Adenocarcinoma : 2008-07-15 : Drug: erlotinib with cetuximab The phase I portion will accrue as many as 3 cohorts of 3-6 patients; rec |
| Completed |
: A Study Examining Maintenance Avastin Monotherapy in Patients With Advanced Lung Adenocarcinoma : Lung Adenocarcinoma : 2014-03-19 |
| Completed |
: Chemotherapy Combined Autologous Cytokine-induced Killer Cells in Naive Stage IV EGFR-wild Type Lung Adenocarcinoma : Lung Adenocarcinoma : 2015-11-25 :
|
| Not yet recruiting |
: Chemotherapy Plus Gefitinib for Advanced Lung Adenocarcinoma and Sensitive EGFR Mutations: a Randomized Controlled Trial : Lung Adenocarcinoma : 2016-10-15 :
|
| Not yet recruiting |
: Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Lung Adenocarcinoma Harboring Wild-type EGFR : Lung Adenocarcinoma : 2016-02-03 :
|